BRCA1 haploinsufficiency leads to altered expression of genes involved in cellular proliferation and development.
The assessment of BRCA1 and BRCA2 coding sequences to identify pathogenic mutations associated with inherited breast/ovarian cancer syndrome has provided a method to identify high-risk individuals, allowing them to seek preventative treatments and strategies. However, the current test is expensive,...
Main Authors: | Harriet E Feilotter, Claire Michel, Paolo Uy, Lauren Bathurst, Scott Davey |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4064996?pdf=render |
Similar Items
-
DEVELOPMENT OF A FUNCTIONAL ASSAY FOR DETERMINATION OF BRCA1 CARRIER STATUS
by: BATHURST, LAUREN
Published: (2014) -
Validation of a Gene-Expression Based Assay for BRCA1 Function
by: Uy, PAOLO MIGUEL
Published: (2013) -
Studies in the cellular effects of proteasomal S4 ATPase haploinsufficiency
by: Rezvani, Zahra Nooshin
Published: (2006) -
Nrg1 haploinsufficiency alters inhibitory cortical circuits
by: Carmen Navarro-Gonzalez, et al.
Published: (2021-09-01) -
Folliculin haploinsufficiency causes cellular dysfunction of pleural mesothelial cells
by: Shouichi Okamoto, et al.
Published: (2021-05-01)